Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Explore the ADPKD drug pipeline: mTOR inhibitors, vasopressin V2 receptor antagonists, anti-miR-17 oligonucleotides, and CFTR modulation strategies shaping PKD treatment.
Article | Report Mapping the 2026 AFM patent landscape: sub-10 nm chemical imaging, semiconductor metrology, AI automation, and the assignees shaping the next frontier.
Article | Report RNA splicing correction and small molecule approaches in the DM1 drug pipeline: ASOs, PPMOs, muscle-targeted conjugates, AAV-RNAi, and MSI2 inhibitors analysed from patent data.
Article | Report Atmospheric vs. low-pressure electrolysis for green hydrogen: patent intelligence on compressor elimination, SPE membranes, and >80 bar electrochemical processes.
Article | Report Patent signals reveal five innovation clusters shaping VIP technology in 2026 — from glass-substrate glazing to predictive monitoring. Explore the full landscape.
Article | Report How does thermophotovoltaic (TPV) energy conversion work, and where is it applied in industrial waste heat recovery? A patent-data deep dive.
Article | Report How does thermophotovoltaic (TPV) energy conversion work, and where is it applied in industrial waste heat recovery? A patent-data deep dive covering key players, materials, and system architectures.
Article | Report Analyse the ovarian cancer drug pipeline: PARP inhibitor combinations, ADC strategies targeting TROP2 and FRα, and next-generation selective PARP1 inhibitor approaches.
Article | Report How does iridium oxide degrade in PEM electrolyzer anodes? Discover the five key mechanisms—dissolution, phase change, interfacial failure, support corrosion, and ionomer encapsulation—from patent analysis.
Article | Report Explore the microwave photonics technology landscape in 2026: where RF engineering meets photonics for 5G/6G, radar beamforming, and chip-scale integration.
Article | Report How does iridium oxide degrade in PEM electrolyzer anodes? A patent-backed analysis of dissolution, phase change, interfacial failure, and support corrosion mechanisms.
Article | Report ADCs, PD-1/PD-L1 checkpoint inhibitors, and HER2-targeted therapies are reshaping the endometrial cancer drug pipeline. Explore the latest patent signals and clinical translation data.
Article | Report A 2026 patent landscape of dielectric elastomer actuator technology: materials breakthroughs, structural architectures, self-sensing, and key assignees shaping the DEA field.
Article | Report Dry electrode manufacturing eliminates toxic NMP solvents and enables scalable solid-state batteries. Explore key process challenges, patent trends, and leading innovators.
Article | Report Anti-PLA2R, felzartamab, obinutuzumab, and BTK inhibitors are reshaping the primary membranous nephropathy drug pipeline. Explore patent signals and clinical data.